MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
Journal Article

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

2016
Request Book From Autostore and Choose the Collection Method
Overview
In this set of four phase 1 studies, a recombinant vesicular stomatitis virus (rVSV)–based Ebola vaccine induced Ebola virus–specific immune responses and was associated with side effects that included fever and transient arthritis, rash, and VSV viremia. In August 2014, after the outbreak of Ebola virus disease was declared a public health emergency of international concern by the World Health Organization (WHO), the Canadian government donated 800 vials of the replication-competent recombinant vesicular stomatitis virus (rVSV)–vectored Zaire ebolavirus (rVSV-ZEBOV) candidate vaccine to the WHO. The VSV Ebola Consortium (VEBCON) was created under the auspices of the WHO to initiate phase 1 studies to facilitate rapid progression to phase 2 and 3 trials in affected countries. 1 Live replicating viral vaccines elicit humoral and cellular immune responses against viral pathogens. 2 , 3 A single injection of 10 million plaque-forming units . . .